Exchange: NASDAQ·Updated 04:55 AM EDT
GNTA logo

GNTAGenenta Science SpA - ADR

$1.61
$0.03
(1.90%)
Pre-Market
Prev Close $1.58
Mkt Cap$37.02M
Vol2,810.00

About

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
9

Frequently Asked Questions

What is Market Cap of Genenta Science SpA - ADR?
What is the 52-week high for Genenta Science SpA - ADR?
What is the 52-week low for Genenta Science SpA - ADR?
What is Genenta Science SpA - ADR stock price today?
What was Genenta Science SpA - ADR stock price yesterday?
What is the PE ratio of Genenta Science SpA - ADR?
What is the Price-to-Book ratio of Genenta Science SpA - ADR?
What is the 50-day moving average of Genenta Science SpA - ADR?
How many employees does Genenta Science SpA - ADR have?

Advertisement|Remove ads.